DXS INTERNATIONAL PLC
RESULT OF ANNUAL GENERAL MEETNG
(“DXSP”)
The Board of DXS International plc (“the Company”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that the Annual General Meeting of the Company was held on Thursday 1 December 2022.
All resolutions as set out in the Notice of Meeting dated 4 November 2022 were passed and copies of the Resolutions are available on the Company’s website
The Directors of DXS International plc accept responsibility for this announcement.
Contacts:
| David Immelman (Chief Executive) DXS International plc |
01252 719800 david@dxs-systems.com |
| https://www.dxs-systems.co.uk |
| Corporate Advisor |
|
| City & Merchant David Papworth |
020 7101 7676 |
| Corporate Broker |
|
| Hybridan LLP Claire Louise Noyce |
020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.